Morikawa H - Search Results

1

Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.

Kawamura E, Shiomi S, Kotani K, Kawabe J, Hagihara A, Fujii H, Uchida-Kobayashi S, Iwai S, Morikawa H, Enomoto M, Murakami Y, Tamori A, Kawada N. Kawamura E, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2014 Sep;29(9):1722-7. doi: 10.1111/jgh.12611. J Gastroenterol Hepatol. 2014. PMID: 24730671

2

Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C.

Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N. Morikawa H, et al. J Gastroenterol. 2011 Mar;46(3):350-8. doi: 10.1007/s00535-010-0301-x. Epub 2010 Aug 10. J Gastroenterol. 2011. PMID: 20697747

3

Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome.

Iwai S, Sakaguchi H, Fujii H, Kobayashi S, Morikawa H, Enomoto M, Tamori A, Kawada N. Iwai S, et al. Among authors: morikawa h. Hepatogastroenterology. 2012 Mar-Apr;59(114):546-50. doi: 10.5754/hge11988. Hepatogastroenterology. 2012. PMID: 22353522

4

A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma.

Hagihara A, Teranishi Y, Kawamura E, Fujii H, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N. Hagihara A, et al. Among authors: morikawa h. Intern Med. 2013;52(14):1589-92. doi: 10.2169/internalmedicine.52.9340. Epub 2013 Jul 15. Intern Med. 2013. PMID: 23857091 Free article. Review.

5

Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated-interferon and ribavirin.

Hai H, Tamori A, Enomoto M, Morikawa H, Uchida-Kobayashi S, Fujii H, Hagihara A, Kawamura E, Thuy le TT, Tanaka Y, Kawada N. Hai H, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2014 Jan;29(1):201-7. doi: 10.1111/jgh.12376. J Gastroenterol Hepatol. 2014. PMID: 23980585

6

Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.

Tamori A, Hino M, Kawamura E, Fujii H, Uchida-Kobayashi S, Morikawa H, Nakamae H, Enomoto M, Murakami Y, Kawada N. Tamori A, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2014 Sep;29(9):1715-21. doi: 10.1111/jgh.12604. J Gastroenterol Hepatol. 2014. PMID: 24730465

7

Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy.

Kozuka R, Hai H, Teranishi Y, Motoyama H, Kawamura E, Hagihara A, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N, Tamori A. Kozuka R, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2017 Aug;32(8):1495-1502. doi: 10.1111/jgh.13743. J Gastroenterol Hepatol. 2017. PMID: 28109022

8

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.

Hai H, Tamori A, Thuy LTT, Yoshida K, Hagihara A, Kawamura E, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N. Hai H, et al. Among authors: morikawa h. Sci Rep. 2017 Sep 19;7(1):11912. doi: 10.1038/s41598-017-10363-5. Sci Rep. 2017. PMID: 28928439 Free PMC article.

9

Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.

Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y. Kozuka R, et al. Among authors: morikawa h. J Gastroenterol Hepatol. 2019 May;34(5):937-946. doi: 10.1111/jgh.14454. Epub 2018 Sep 26. J Gastroenterol Hepatol. 2019. PMID: 30160782

10

Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.

Iida-Ueno A, Enomoto M, Uchida-Kobayashi S, Hagihara A, Teranishi Y, Fujii H, Morikawa H, Murakami Y, Tamori A, Thuy LTT, Kawada N. Iida-Ueno A, et al. Among authors: morikawa h. Cancer Chemother Pharmacol. 2018 Nov;82(5):857-864. doi: 10.1007/s00280-018-3681-x. Epub 2018 Sep 3. Cancer Chemother Pharmacol. 2018. PMID: 30178114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters